Edith A Perez: Influence Statistics

Edith A Perez

Edith A Perez

Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL USA | Hematology and Oncology, Mayo Clinic, Rochester, MN

Edith A Perez: Expert Impact

Concepts for which Edith A Perez has direct influence: Metastatic breast cancer , Metastatic breast , Patients docetaxel , Neoadjuvant therapy , Paclitaxel docetaxel , Docetaxel paclitaxel , Nail toxicity .

Edith A Perez: KOL impact

Concepts related to the work of other authors for which for which Edith A Perez has influence: Neoadjuvant therapy , Cell lung , Pathological complete response , Weekly docetaxel , Resectable nsclc , Pathologic assessment , Double sleeve lobectomy .

KOL Resume for Edith A Perez

Year
2021

Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL USA

2018

Hematology and Oncology, Mayo Clinic, Rochester, MN

Prominent publications by Edith A Perez

KOL-Index: 3377 . This Review Article provides a multi-stakeholder view on the current status of neoadjuvant therapy in lung cancer. Given the success of oncogene-targeted therapy and immunotherapy for patients with advanced lung cancer, there is a renewed interest in studying these agents in earlier disease settings with the opportunity to have an even greater impact on patient outcomes. There are unique ...
Known for Neoadjuvant Therapy | Lung Cancer | Pathologic Response | Prognosis Antineoplastic
KOL-Index: 2664 . The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly improved survival in several cancer settings. A subgroup of women with breast cancer (BC) has immunogenic infiltration of lymphocytes with expression of programmed death-ligand 1 (PD-L1). These patients may potentially benefit from ICI targeting the programmed death 1 (PD-1)/PD-L1 signaling axis. The use ...
Known for Breast Cancer | Lymphocytes Tils | Checkpoint Inhibitors | Tumor Infiltrating
KOL-Index: 1170
Known for Nail Toxicity | Antineoplastic Agents | Paclitaxel Pigmentation | Phytogenic Breast
KOL-Index: 980
Known for Monoclonal Antibodies | Combined Chemotherapy
KOL-Index: 245
Known for Doxorubicin Cardiotoxicity | Heart Diseases

Key People For Metastatic Breast Cancer

Top KOLs in the world
#1
Gabriel N Hortobagyi
breast cancer neoadjuvant chemotherapy estrogen receptors
#2
Aman U Buzdar
breast cancer neoadjuvant chemotherapy postmenopausal women
#3
Jose M Baselga
breast cancer monoclonal antibodies advanced solid tumors
#4
Eric P Winer
breast cancer adjuvant chemotherapy brain metastases
#5
Larry Norton
breast cancer adjuvant chemotherapy monoclonal antibodies
#6
Veronique C Diéras
breast cancer trastuzumab emtansine brain metastases

Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL USA | Hematology and Oncology, Mayo Clinic, Rochester, MN